Related Experiment Video
Updated: Mar 9, 2026

08:07
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
10.7K
Polyreactive natural antibodies in transplantation
1Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York, USA.
Current Opinion in Organ Transplantation
|December 23, 2016
Summary
Natural antibodies (Nabs) contribute to antibody-mediated rejection (ABMR) after organ transplant. Elevated IgG Nabs are linked to ABMR and late graft loss, highlighting their pathogenic potential in transplantation.
Area of Science:
- Immunology
- Transplantation Science
- Autoimmunity
Background:
- Antibody-mediated rejection (ABMR) is a major cause of late graft loss in solid organ transplantation.
- Autoantibodies, including natural antibodies (Nabs), are increasingly recognized alongside anti-HLA antibodies in the humoral response to allografts.
- Nabs, secreted by innate B cells, can bind to altered self-antigens like oxidized lipids on apoptotic cells.
Purpose of the Study:
- To review the role of natural antibodies (Nabs) in the pathophysiology of antibody-mediated rejection (ABMR).
- To highlight the emerging evidence implicating Nabs in late graft loss following solid organ transplantation.
Main Methods:
- This is a review article, synthesizing existing research.
- Analysis of recent findings on the contribution of immunoglobulin (Ig) G Nabs to ABMR.
- Examination of the association between pretransplant IgG Nabs levels and graft outcomes.
Main Results:
- New evidence supports the contribution of IgG Nabs to ABMR.
- Significantly higher serum IgG Nabs levels were observed in patients with ABMR compared to controls with stable graft function.
- Pretransplant IgG Nabs are associated with ABMR and late graft loss, with IgG1 and IgG3 subclasses capable of complement activation.
Conclusions:
- Nabs are significant components of the host immune response to solid organ grafts.
- The identified role of Nabs in ABMR and late kidney graft loss necessitates further investigation.
- Understanding Nab pathogenicity is crucial for improving transplant outcomes.
Related Concept Videos
Cross-reactivity
33.6K
Overview
33.6K
Cell-mediated Immune Responses
85.5K
Overview
85.5K
Tissue Transplantation
1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Blood Transfusion and Agglutination
15.3K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.3K
Diversity of Antigen Receptors
1.9K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.9K
Hybridoma Technology
18.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
18.1K

